Pharmaceuticals South Africa

South Africa Stem Cell Therapy Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

South Africa Stem Cell Therapy Market Industry Trends and Forecast to 2034: Segmented by (Cell Type, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

South Africa · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $17.8 Mn Placeholder estimate
Estimate 2025 $20.8 Mn 0.6% of the global market
Projected 2034 $82.9 Mn 298.4% Adds $62.1 Mn over 9 forecast years
CAGR 2025–2034 16.6% Faster than 78% of 180 Pharmaceuticals markets here
Key players 5
  • South Africa is 0.63% of the global market.
  • In Africa, the largest is South Africa (this report) at $20.8 Mn.
  • Fastest growing: Egypt at 16.7% a year.
  • South Africa ranks 1st of 3 by size in Africa.

Market size projection

South Africa

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$62.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Stem Cell Therapy Market market size by year, South Africa
YearMarket sizeChange that yearSince 2025
2024 (estimate) $17.8 Mn — —
2025 (base) $20.8 Mn +$3.0 Mn —
2026 (forecast) $24.3 Mn +$3.5 Mn +16.6%
2027 (forecast) $28.3 Mn +$4.0 Mn +36%
2028 (forecast) $33.0 Mn +$4.7 Mn +58.5%
2029 (forecast) $38.4 Mn +$5.5 Mn +84.8%
2030 (forecast) $44.8 Mn +$6.4 Mn +115.5%
2031 (forecast) $52.3 Mn +$7.4 Mn +151.3%
2032 (forecast) $61.0 Mn +$8.7 Mn +193%
2033 (forecast) $71.1 Mn +$10.1 Mn +241.7%
2034 (forecast) $82.9 Mn +$11.8 Mn +298.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

South Africa Stem Cell Therapy Market Analysis at a glance
Market size, 2025$20.8 Mn placeholder estimate
Forecast, 2034$82.9 Mn placeholder estimate
Growth (CAGR), 2025–203416.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsCell type, indication and end user (see all)
Key playersMesoblast, Vertex Pharmaceuticals, Takeda Pharmaceutical Company Ltd, Pluri, BlueRock Therapeutics (Bayer) (see all)
Regulator in South AfricaSAHPRASource: South African Health Products Regulatory Authority. Checked 14 Nov 2026.
Active clinical trials2 in South AfricaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in South Africa. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The South Africa Stem Cell Therapy Market Analysis Executive Summary

Stem cell therapies use stem cells to repair or replace damaged tissue, for blood disorders, joints, heart and nerve conditions.

Key segments of the stem Cell Therapy market include cell type (Mesenchymal Stem Cells, Hematopoietic Stem Cells and Induced Pluripotent Stem Cells) and indication (Musculoskeletal, Cardiovascular and Neurological).

Bar chart: South Africa Stem Cell Therapy market size, 2024–2034, placeholder estimates. $17.8 Mn in 2024, $20.8 Mn in 2025 and $82.9 Mn in 2034, 16.6% CAGR.
South Africa Stem Cell Therapy market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

South Africa Stem Cell Therapy Market Dynamics

Market Growth Drivers

Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the stem Cell Therapy market.

Opportunity

Allogeneic (off-the-shelf) products, in-vivo delivery and use in common diseases open large growth for the stem Cell Therapy market.

Market Restraints

Very high prices, complex manufacturing, limited treatment centres and uncertain long-term safety hold back the stem Cell Therapy market. Payers are still working out how to pay for one-time cures.

Competitive Landscape for Stem Cell Therapy Market in South Africa

The stem Cell Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Stem Cell Therapy Market in South Africa

Stem Cell Therapy in South Africa: rules, payment and research

The South African Health Products Regulatory Authority (SAHPRA) registers medicines.⁠[1] Most people use public health services and a minority belong to private medical schemes; the National Health Insurance Act, signed in May 2024, plans to fund care for everyone.⁠[2] ClinicalTrials.gov lists 2 studies on Stem Cell Therapy that are recruiting, active or about to start in South Africa.⁠[3]

[1] South African Health Products Regulatory Authority. Checked 14 Nov 2026.

[2] National Department of Health. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in South Africa. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for stem Cell Therapy. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in South Africa.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Stem Cell Therapy right now, from free public sources.

Clinical trials

2 active trials in South Africa

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. PT. Prodia Stem Cell Indonesia 6 active trials on ClinicalTrials.gov (opens in a new tab)
  2. XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. 5 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Nuwacell Biotechnologies Co., Ltd. 5 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Regend Therapeutics 5 active trials on ClinicalTrials.gov (opens in a new tab)
  5. LucasBio 5 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Stem Cell Therapy in context

South Africa compared

  • Health spending per person: 537 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 17 countries we cover in Africa.[1]
  • Doctors: 0.79 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 17 countries we cover in Africa.[2]
  • People aged 65 and over: 6.9% of people (2025). World: 10.4% of people (2025). 2nd highest of the 17 countries we cover in Africa.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Stem Cell Therapy market in South Africa?
Placeholder estimate: about $20.8 Mn in 2025, rising to about $82.9 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Stem Cell Therapy market in South Africa growing?
Placeholder estimate: about 16.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Stem Cell Therapy market report cover?
The report splits the market by cell type (Mesenchymal Stem Cells, Hematopoietic Stem Cells, Induced Pluripotent Stem Cells), indication (Musculoskeletal, Cardiovascular, Neurological, Blood Disorders) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Stem Cell Therapy market?
Key players include Mesoblast, Vertex Pharmaceuticals, Takeda Pharmaceutical Company Ltd, Pluri and BlueRock Therapeutics (Bayer).
What is driving the Stem Cell Therapy market?
Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the stem Cell Therapy market.
Who regulates Stem Cell Therapy in South Africa?
The South African Health Products Regulatory Authority (SAHPRA) registers medicines. Source: South African Health Products Regulatory Authority. Checked 14 Nov 2026.
How is healthcare paid for in South Africa?
Most people use public health services and a minority belong to private medical schemes; the National Health Insurance Act, signed in May 2024, plans to fund care for everyone. Source: National Department of Health. Checked 14 Nov 2026.
How many clinical trials on Stem Cell Therapy are running in South Africa?
2 studies are recruiting, active or about to start in South Africa, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in South Africa. Retrieved 12 Nov 2026.
How much research is published on Stem Cell Therapy?
PubMed lists 4,354 papers on Stem Cell Therapy added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in South Africa

See all